[734] DOG-1 Expression in Detection of Gastrointestinal Stromal Tumors
AC Schmitt, C Cohen, MT Siddiqui. Emory University Hospital, Atlanta, GA
Background: Gastrointestinal stromal tumors (GIST) are characterized by KIT or PDGFRA activating mutations. The diagnosis of GIST relies on C-Kit immunohistochemical (IHC) detection; however up to 15% of GIST are C-Kit negative. Antibodies with increased sensitivity in the detection of C-kit negative GIST cases could be of value, as they might also benefit from imatinib mesylate therapy. Gene expression profiling studies have identified two novel proteins strongly expressed in GIST: DOG-1 and protein kinase C- theta (PKCθ), a signaling molecule important in T-cell activation. DOG-1 is a protein of unknown function highly expressed in GIST, irrespective of KIT or PDGFRA mutation status. Compared to C-Kit, it is rarely expressed in other soft tissue tumors. We investigated two DOG-1 antibody clones, to determine their use in the diagnosis of GIST, especially C-Kit negative GIST.
Design: IHC was performed on 40 GIST, 5 adenoid cystic carcinomas (ACC), 5 mastocytomas (MC), and 5 pure seminomas (SEM). The staining pattern of two DOG-1 mouse monoclonal antibody clones, (Cell Marque SP31 and Leica Microsystems K9); two C-Kit antibody clones, (DakoCytomation polyclonal antibody [pC-Kit], and Novocastra T595 monoclonal antibody [mC-Kit]); and BD Biosciences PKCθ monoclonal antibody was analyzed.
Results:
| DOG-1 (SP31) | DOG-1 (K9) | pC-Kit | mC-Kit | PKCθ | |
| GIST | 38/40 | 36/40 | 28/40 | 22/40 | 23/40 |
| ACC | 0 | 0 | 5/5 | 5/5 | 0 |
| MC | 0 | 0 | 4/5 | 4/5 | 0 |
| SEM | 0 | 0 | 5/5 | 4/5 | 0 |
| DOG-1 (SP31) | DOG-1 (K9) | pC-Kit | mC-Kit | PKCθ | |
| Sensitivity | 0.95 | 0.90 | 0.70 | 0.55 | 0.57 |
| Specificity | 1.00 | 1.00 | 0.06 | 0.13 | 1.00 |